Welcome to LookChem.com Sign In|Join Free

CAS

  • or

16081-87-1

Post Buying Request

16081-87-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

16081-87-1 Usage

General Description

Pyrido[2,3-d]pyrimidin-4(1H)-one, 2-phenyl- is a chemical compound with a pyrimidine ring fused with a pyridine ring and a phenyl group attached to the second position of the pyrimidine ring. It is commonly used as a building block in organic synthesis and pharmaceutical research. Pyrido[2,3-d]pyrimidin-4(1H)-one, 2-phenyl- has been studied for its potential biological activities, including as an antitumor agent, an inhibitor of protein kinases, and a potential treatment for cardiovascular diseases. Its structure and properties make it a versatile and important chemical in the field of medicinal chemistry and drug development.

Check Digit Verification of cas no

The CAS Registry Mumber 16081-87-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,0,8 and 1 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 16081-87:
(7*1)+(6*6)+(5*0)+(4*8)+(3*1)+(2*8)+(1*7)=101
101 % 10 = 1
So 16081-87-1 is a valid CAS Registry Number.

16081-87-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-phenyl-1H-pyrido[2,3-d]pyrimidin-4-one

1.2 Other means of identification

Product number -
Other names 2-Phenyl-pyrido<2.3-d>pyrimidon-(4)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16081-87-1 SDS

16081-87-1Relevant articles and documents

An efficient transition-metal-free route to quinazolin-4(3H)-onesvia2-aminobenzamides and thiols

Dong, Yibo,Wu, Yangjie,Yan, Congcong,Yang, Jinchen,Zhang, Jinli

supporting information, p. 15344 - 15349 (2021/09/07)

An efficient approach to quinazolin-4(3H)-ones was developed by a one-pot intermolecular annulation reaction ofo-amino benzamides and thiols. This method has the features of good functional group tolerance, being transition metal and external oxidant free, and easy operation. Varieties of 2-aryl (heteroaryl) quinazolin-4(3H)-one, 2-phenyl-pyrido[2,3-d]pyrimidin-4(3H)-one and 3-phenyl-2H-1,2,4-benzo thiadiazine-1,1-dioxide derivatives were obtained with a yield of up to 98%. The control experiment revealed that the thiol substrate could promote the dehydroaromatization step.

Synthesis of 2-aryl quinazolinones: Via iron-catalyzed cross-dehydrogenative coupling (CDC) between N-H and C-H bonds

Jang, Yoonkyung,Lee, Seok Beom,Hong, Junhwa,Chun, Simin,Lee, Jeeyeon,Hong, Suckchang

supporting information, p. 5435 - 5441 (2020/08/03)

Herein, we describe the direct synthesis of quinazolinones via cross-dehydrogenative coupling between methyl arenes and anthranilamides. The C-H functionalization of the benzylic sp3 carbon is achieved by di-t-butyl peroxide under air, and the subsequent amination-aerobic oxidation process completes the annulation process. Iron catalyzed the whole reaction process and various kinds of functional groups were tolerated under the reaction conditions, providing 31 examples of 2-aryl quinazolinones using methyl arene derivatives in yields of 57-95percent. The synthetic potential has been demonstrated by the additional synthesis of aryl-containing heterocycles. This journal is

New Inhibitors of Breast Cancer Resistance Protein (ABCG2) Containing a 2,4-Disubstituted Pyridopyrimidine Scaffold

Krapf, Michael K.,Gallus, Jennifer,Vahdati, Sahel,Wiese, Michael

, p. 3389 - 3408 (2018/05/01)

Multidrug resistance (MDR) occurring during cancer chemotherapy is a major obstacle for effectiveness and response to therapy and is often caused by ATP-binding cassette (ABC) efflux transporters. Belonging to the family of ABC transporters, breast cancer

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 16081-87-1